|
Published by: Global Markets Direct
Published: Sep. 30, 2008 - 133 Pages
Table of Contents
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Definitions
- 2.2.1 Drug delivery devices
- 2.2.1.1 Needle-free Injections
- 2.2.1.2 Inhalation Systems
- 2.2.1.3 Infusion Systems
- 3 Healthcare Sector Review
- 3.1 Healthcare Expenditure
- 3.2 Healthcare Infrastructure
- 3.3 Healthcare Policy
- 4 Drug Delivery Devices in Brazil
- 4.1 Drug Delivery Devices Overall Revenues (2000-2012)
- 4.2 Drug Delivery Devices Overall Volume (2000-2012)
- 4.3 Drug Delivery Devices Company Shares (2005-2006)
- 5 Inhalation Systems in Brazil
- 5.1 Inhalation Systems Overall Revenues (2000-2012)
- 5.1.1 Metered Dose Inhaler Devices Overall Revenues (2000-2012)
- 5.1.2 Dry Powder Inhaler Devices Overall Revenues (2000-2012)
- 5.2 Inhalation Systems Overall Volume (2000-2012)
- 5.2.1 Metered Dose Inhaler Devices Overall Volume (2000-2012)
- 5.2.2 Dry Powder Inhaler Devices Overall Volume (2000-2012)
- 5.3 Inhalation Systems Average Price (2000-2012)
- 5.3.1 Metered Dose Inhaler Devices Average Price (2000-2012)
- 5.3.2 Dry Powder Inhaler Devices Average Price (2000-2012)
- 5.4 Inhalation Systems Distribution Share (2005-2006)
- 5.5 Inhalation Systems Company Share (2005-2006)
- 6 Infusion Systems in Brazil
- 6.1 Infusion Systems Overall Revenues (2000-2012)
- 6.1.1 Infusion Disposable Sets Overall Revenue (2000-2012)
- 6.1.2 Infusion Pumps Overall Revenue (2000-2012)
- 6.1.3 Syringe Pumps Overall Revenues (2000-2012)
- 6.2 Infusion Systems Overall Volume (2000-2012)
- 6.2.1 Infusion Disposables Sets Overall Volume (2000-2012)
- 6.2.2 Infusion Pumps Overall Volume (2000-2012)
- 6.2.3 Syringe Pumps Overall Volume (2000-2012)
- 6.3 Infusion Systems Average Price (2000-2012)
- 6.3.1 Infusion Pumps Average Price (2000-2012)
- 6.3.2 Syringe Pumps Average Price (2000-2012)
- 6.3.3 Infusion Disposable Sets Average Price (2000-2012)
- 6.4 Infusion Systems Distribution Share (2005-2006)
- 6.5 Infusion Systems Company Share (2005-2006)
- 7 AstraZeneca PLC Company Profile
- 7.1 Company Overview
- 7.2 Business Overview
- 7.2.1 Products
- 7.2.2 History
- 7.3 Locations And Subsidiaries
- 8 3M Company Profile
- 8.1 Company Overview
- 8.2 Business Overview
- 8.2.1 Consumer and Office
- 8.2.1.1 Overview
- 8.2.1.2 Capital Expenditure
- 8.2.1.3 Market View
- 8.2.1.4 Key Strategies
- 8.2.2 Display and Graphics
- 8.2.2.1 Overview
- 8.2.2.2 Financials
- 8.2.2.3 Capital Expenditure
- 8.2.2.4 Market View
- 8.2.2.5 Key Strategies
- 8.2.3 Electro and Communications
- 8.2.3.1 Overview
- 8.2.3.2 Financials
- 8.2.3.3 Capital Expenditure
- 8.2.3.4 Market View
- 8.2.3.5 Key Strategies
- 8.2.4 Health Care
- 8.2.4.1 Overview
- 8.2.4.2 Financials
- 8.2.4.3 Capital Expenditure
- 8.2.4.4 Market View
- 8.2.4.5 Key Strategies
- 8.2.5 Industrial and Transportation
- 8.2.5.1 Overview
- 8.2.5.2 Financials
- 8.2.5.3 Capital Expenditure
- 8.2.5.4 Market View
- 8.2.5.5 Key Strategies
- 8.2.6 Safety, Security and Protection Services
- 8.2.6.1 Overview
- 8.2.6.2 Financials
- 8.2.6.3 Capital Expenditure
- 8.2.6.4 Market View
- 8.2.6.5 Key Strategies
- 8.2.7 Products
- 8.3 Value Chain Analysis
- 8.3.1 Manufacturing
- 8.3.1.1 In House Manufacturing
- 8.3.2 Product Development
- 8.3.2.1 Regulatory Approvals
- 8.3.2.2 Clinical Trials
- 8.3.2.3 Research and Development
- 8.3.3 Sales and Marketing
- 8.3.3.1 Partnerships and Alliances
- 8.3.3.2 Licensing Agreements
- 8.3.3.3 E-distribution
- 8.4 SWOT Analysis
- 8.4.1 3M Company Strengths
- 8.4.1.1 Strong performance of Industrial and Transportation segment
- 8.4.1.2 Focused research and development
- 8.4.1.3 Decentralized operations
- 3M Company Weaknesses
- 8.4.1.4 Increased operating costs in the U.S.
- 8.4.1.5 Personal care segment’s poor performance
- 3M Company Opportunities
- 8.4.1.6 Expanding global presence
- 8.4.1.7 The liquid crystal display
- 8.4.1.8 Enhancing brand portfolio
- 3M Company Threats
- 8.4.1.9 Foreign currency fluctuations
- 8.4.1.10 Increasing cost of raw materials
- 8.4.1.11 Trend for private labels
8.5 Revenue Analysis - 8.5.1 Revenue by Segment
- 8.5.2 Revenue by Geography
8.6 Financial and Operational Review - 8.6.1 Financial Statements
- 8.6.2 Financial Ratios
8.7 Locations And Subsidiaries 9 Baxter International Company Profile 9.1 Company Overview 9.2 Business Overview - 9.2.1 BioScience
- 9.2.1.1 Overview
- 9.2.1.2 Financials
- 9.2.1.3 Capital Expenditure
- 9.2.2 Medication Delivery
- 9.2.2.1 Overview
- 9.2.2.2 Financials
- 9.2.2.3 Capital Expenditure
- 9.2.3 Renal
- 9.2.3.1 Overview
- 9.2.3.2 Financials
- 9.2.3.3 Capital Expenditure
- 9.2.4 Products
- 9.2.5 History
9.3 Value Chain Analysis - 9.3.1 Manufacturing
- 9.3.1.1 In House Manufacturing
- 9.3.2 Product Development
- 9.3.2.1 Regulatory Approvals
- 9.3.2.2 Clinical Trials
- 9.3.2.3 Research and Development
- 9.3.3 Sales and Marketing
- 9.3.3.1 Partnerships and Alliances
9.4 SWOT Analysis - 9.4.1 Baxter International Inc. Strengths
- 9.4.1.1 Diversified geographic presence
- 9.4.1.2 Sturdy research and development activities
- 9.4.1.3 Strong financial performance
- 9.4.2 Baxter International Inc. Weaknesses
- 9.4.2.1 High levels of inventory
- 9.4.2.2 Decline in revenues of medication delivery
- 9.4.2.3 Reduced capital expenditure
- 9.4.3 Baxter International Inc. Opportunities
- 9.4.3.1 Co-developing alliances
- 9.4.3.2 Increasing End Stage Renal Disease patients
- 9.4.3.3 FDA approval
- 9.4.4 Baxter International Inc. Threats
- 9.4.4.1 Legal proceedings
- 9.4.4.2 Patent litigation
- 9.4.4.3 Stringent regulations
9.5 Revenue Analysis - 9.5.1 Revenue by Segment
- 9.5.2 Revenue by Geography
9.6 Financial and Operational Review - 9.6.1 Financial Statements
- 9.6.2 Financial Ratios
9.7 Locations And Subsidiaries 9.8 Baxter International Inc. Pipeline Products - 9.8.1 Next-Generation Home Hemodialysis Machine
- 9.8.1.1 Product Overview
- 9.8.1.2 Product Description
- 9.8.1.3 Product Status
- 9.8.1.4 Product Milestone
10 GlaxoSmithKline plc Company Profile 10.1 Company Overview 10.2 Business Overview - 10.2.1 Products
- 10.2.2 History
10.3 Locations And Subsidiaries 11 Novartis AG Company Profile 11.1 Company Overview 11.2 Business Overview - 11.2.1 Major Products and Services
11.3 Locations And Subsidiaries 12 Regulation System 12.1 Medical Device Registration Protocol - 12.1.1 Registration Documentation
- 12.1.2 Registration Procedure
- 12.1.3 Medical Device Registration Fee
13 Pricing and Reimbursement 14 Distribution Structure 15 Appendix 15.1 Global Markets Direct Research Methodology 15.2 Coverage 15.3 Secondary Research 15.4 Primary Research 15.5 Models 15.6 Forecasts 15.7 Expert Panels 15.8 Currency Conversion 15.9 Contact Us 15.10 Disclaimer 1.1 List of TablesTable 1: Drug Delivery Devices, Brazil, Overall Revenues ($ mn), 2000-2012 Table 2: Drug Delivery Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Table 3: Drug Delivery Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Table 4: Drug Delivery Devices, Brazil, Category Revenues ($ mn), 2000-2012 Table 5: Drug Delivery Devices, Brazil, Category Revenues ($ mn), Historic, 2000-2007 Table 6: Drug Delivery Devices, Brazil, Category Revenues ($ mn), Forecast, 2007-2012 Table 7: Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2012 Table 8: Drug Delivery Devices, Brazil, Category Volume (Units), Historic, 2000-2007 Table 9: Drug Delivery Devices, Brazil, Category Volume (Units), Forecast, 2007-2012 Table 10: Drug Delivery Devices, Brazil, Company Share by Revenue ($ mn), 2005-2006 Table 11: Inhalation Systems, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Table 12: Inhalation Systems, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Table 13: Inhalation Systems, Brazil, Revenue by Segment ($ mn), Historic, 2000-2007 Table 14: Inhalation Systems, Brazil, Revenue by Segment ($ mn), Forecast, 2007-2012 Table 15: Metered Dose Inhaler Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Table 16: Metered Dose Inhaler Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Table 17: Dry Powder Inhaler Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Table 18: Dry Powder Inhaler Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Table 19: Inhalation Systems, Brazil, Overall Volume (Units), Historic, 2000-2007 Table 20: Inhalation Systems, Brazil, Overall Volume (Units), Forecast, 2007-2012 Table 21: Metered Dose Inhaler Devices, Brazil, Overall Volume (Units), Historic, 2000-2007 Table 22: Metered Dose Inhaler Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 Table 23: Dry Powder Inhaler Devices, Brazil, Overall Volume (Units), Historic, 2000-2007 Table 24: Dry Powder Inhaler Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 Table 25: Metered Dose Inhaler Devices, Brazil, Average Price ($), Historic, 2000-2007 Table 26: Metered Dose Inhaler Devices, Brazil, Average Price ($), Forecast, 2007-2012 Table 27: Dry Powder Inhaler Devices, Brazil, Average Price ($), Historic, 2000-2007 Table 28: Dry Powder Inhaler Devices, Brazil, Average Price ($), Forecast, 2007-2012 Table 29: Inhalation Systems, Brazil, Distribution Share by Revenue ($ mn), 2005-2006 Table 30: Inhalation Systems, Brazil, Company Share by Revenue ($ mn), 2005-2006 Table 31: Infusion Systems, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Table 32: Infusion Systems, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Table 33: Infusion Systems, Brazil, Revenue by Segment ($ mn), Historic, 2000-2007 Table 34: Infusion Systems, Brazil, Revenue by Segment ($ mn), Forecast, 2007-2012 Table 35: Infusion Disposable Sets, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Table 36: Infusion Disposable Sets, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Table 37: Infusion Pumps, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Table 38: Infusion Pumps, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Table 39: Syringe Pumps, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Table 40: Syringe Pumps, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Table 41: Infusion Systems, Brazil, Overall Volume (Units), Historic, 2000-2007 Table 42: Infusion Systems, Brazil, Overall Volume (Units), Forecast, 2007-2012 Table 43: Infusion Disposable Sets, Brazil, Overall Volume (Units), Historic, 2000-2007 Table 44: Infusion Disposable Sets, Brazil, Overall Volume (Units), Forecast, 2007-2012 Table 45: Infusion Pumps, Brazil, Overall Volume (Units), Historic, 2000-2007 Table 46: Infusion Pumps, Brazil, Overall Volume (Units), Forecast, 2007-2012 Table 47: Syringe Pumps, Brazil, Overall Volume (Units), Historic, 2000-2007 Table 48: Syringe Pumps, Brazil, Overall Volume (Units), Forecast, 2007-2012 Table 49: Infusion Pumps, Brazil, Average Price ($), Historic, 2000-2007 Table 50: Infusion Pumps, Brazil, Average Price ($), Forecast, 2007-2012 Table 51: Syringe Pumps, Brazil, Average Price ($), Historic, 2000-2007 Table 52: Syringe Pumps, Brazil, Average Price ($), Forecast, 2007-2012 Table 53: Infusion Disposable Sets, Brazil, Average Price ($), Historic, 2000-2007 Table 54: Infusion Disposable Sets, Brazil, Average Price ($), Forecast, 2007-2012 Table 55: Infusion Systems, Brazil, Distribution Share by Revenue ($ mn), 2005-2006 Table 56: Infusion Systems, Brazil, Company Share by Revenue ($ mn), 2005-2006 Table 57: AstraZeneca PLC, Subsidiaries Table 58: AstraZeneca PLC, Subsidiaries(Contd..) Table 59: 3M Company, SWOT Analysis, 2006 Table 60: 3M Company, Revenue by Segment, USD Million, 2003-2007 Table 61: 3M Company, Revenue by Geography, USD Million, 2003-2007 Table 62: 3M Company, Financial Statements, USD Million, 2003-2007 Table 63: 3M Company, Financial Ratios, USD Million, 2003-2007 Table 64: 3M Company, Subsidiaries Table 65: Baxter International Inc., SWOT Analysis, 2006 Table 66: Baxter International Inc., Revenue by Segment, USD Million, 2003-2007 Table 67: Baxter International Inc., Revenue by Geography, USD Million, 2003-2007 Table 68: Baxter International Inc., Financial Statements, USD Million, 2003-2007 Table 69: Baxter International Inc., Financial Ratios, USD Million, 2003-2007 Table 70: Baxter International Inc., Other Locations Table 71: Baxter International Inc., Subsidiaries Table 72: GlaxoSmithKline plc, Subsidiaries Table 73: GlaxoSmithKline plc, Subsidiaries(Contd..) Table 74: Novartis Medical Nutrition, Other Locations Table 75: Novartis Medical Nutrition, Other Locations(Contd..) Table 76: Medical Device Registration Fee in Brazil, 2002 Table 77: Currency Conversion from USD to Local Currency at 2007 Constant Rate 11.2 List of FiguresFigure 1: Health Expenditure by Source in Brazil, 1996 Figure 2: Drug Delivery Devices, Brazil, Overall Revenues ($ mn), 2000-2012 Figure 3: Drug Delivery Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Figure 4: Drug Delivery Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Figure 5: Drug Delivery Devices, Brazil, Category Revenues ($ mn), 2000-2012 Figure 6: Drug Delivery Devices, Brazil, Category Revenues ($ mn), Historic, 2000-2007 Figure 7: Drug Delivery Devices, Brazil, Category Revenues ($ mn), Forecast, 2007-2012 Figure 8: Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2012 Figure 9: Drug Delivery Devices, Brazil, Category Volume (Units), Historic, 2000-2007 Figure 10: Drug Delivery Devices, Brazil, Category Volume (Units), Forecast, 2007-2012 Figure 11: Drug Delivery Devices, Brazil, Company Share (%), 2006 Figure 12: Inhalation Systems, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Figure 13: Inhalation Systems, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Figure 14: Inhalation Systems, Brazil, Revenue by Segment ($ mn), Historic, 2000-2007 Figure 15: Inhalation Systems, Brazil, Revenue by Segment ($ mn), Forecast, 2007-2012 Figure 16: Metered Dose Inhaler Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Figure 17: Metered Dose Inhaler Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Figure 18: Dry Powder Inhaler Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Figure 19: Dry Powder Inhaler Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Figure 20: Inhalation Systems, Brazil, Overall Volume (Units), Historic, 2000-2007 Figure 21: Inhalation Systems, Brazil, Overall Volume (Units), Forecast, 2007-2012 Figure 22: Metered Dose Inhaler Devices, Brazil, Overall Volume (Units), Historic, 2000-2007 Figure 23: Metered Dose Inhaler Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 Figure 24: Dry Powder Inhaler Devices, Brazil, Overall Volume (Units), Historic, 2000-2007 Figure 25: Dry Powder Inhaler Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 Figure 26: Metered Dose Inhaler Devices, Brazil, Average Price ($), Historic, 2000-2007 Figure 27: Metered Dose Inhaler Devices, Brazil, Average Price ($), Forecast, 2007-201 2 Figure 28: Dry Powder Inhaler Devices, Brazil, Average Price ($), Historic, 2000-2007 Figure 29: Dry Powder Inhaler Devices, Brazil, Average Price ($), Forecast, 2007-2012 Figure 30: Inhalation Systems, Brazil, Distribution Share (%), 2006 Figure 31: Inhalation Systems, Brazil, Company Share (%), 2006 Figure 32: Infusion Systems, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Figure 33: Infusion Systems, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Figure 34: Infusion Systems, Brazil, Revenue by Segment ($ mn), Historic, 2000-2007 Figure 35: Infusion Systems, Brazil, Revenue by Segment ($ mn), Forecast, 2007-2012 Figure 36: Infusion Disposable Sets, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Figure 37: Infusion Disposable Sets, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Figure 38: Infusion Pumps, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Figure 39: Infusion Pumps, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Figure 40: Syringe Pumps, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 Figure 41: Syringe Pumps, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 Figure 42: Infusion Disposable Sets, Brazil, Overall Volume (Units), Historic, 2000-2007 Figure 43: Infusion Disposable Sets, Brazil, Overall Volume (Units), Forecast, 2007-2012 Figure 44: Infusion Pumps, Brazil, Overall Volume (Units), Historic, 2000-2007 Figure 45: Infusion Pumps, Brazil, Overall Volume (Units), Forecast, 2007-2012 Figure 46: Syringe Pumps, Brazil, Overall Volume (Units), Historic, 2000-2007 Figure 47: Syringe Pumps, Brazil, Overall Volume (Units), Forecast, 2007-2012 Figure 48: Infusion Pumps, Brazil, Average Price ($), Historic, 2000-2007 Figure 49: Infusion Pumps, Brazil, Average Price ($), Forecast, 2007-2012 Figure 50: Syringe Pumps, Brazil, Average Price ($), Historic, 2000-2007 Figure 51: Syringe Pumps, Brazil, Average Price ($), Forecast, 2007-2012 Figure 52: Infusion Disposable Sets, Brazil, Average Price ($), Historic, 2000-2007 Figure 53: Infusion Disposable Sets, Brazil, Average Price ($), Forecast, 2007-2012 Figure 54: Infusion Systems, Brazil, Distribution Share (%), 2006 Figure 55: Infusion Systems, Brazil, Company Share (%), 2006 Figure 56: 3M Company, Value Chain Analysis Figure 57: Baxter International Inc., Value Chain Analysis Figure 58: Global Markets Direct Methodology AbstractBrazil Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
Summary
This report is an essential source for in-depth information and data relating to the Brazil drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Brazil
Scope- The report provides drug delivery devices information broken down into detailed categories and segments in Brazil.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy- Gain a strong understanding of the drug delivery devices market in Brazil.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
